Pleural And Chest Wall Disorders

Historical Context & Clinical Motivation

Disorders of the pleura and chest wall have fascinated physicians since antiquity, as the mechanics of respiration depend critically on the integrity of the thoracic cavity. Hippocrates himself described the drainage of empyema in the fifth century BCE, employing open thoracotomy techniques that would persist in various forms for millennia. The development of modern understanding of pleural physiology accelerated dramatically with the advent of thoracentesis, imaging, and eventually video-assisted thoracic surgery. Recognizing these disorders is a cornerstone of pulmonary medicine because the pleural space, though normally containing only a thin film of fluid, can accumulate liters of pathological fluid or air, producing life-threatening respiratory compromise. For Step 2, the ability to rapidly differentiate pleural effusion types, identify pneumothorax, and recognize chest wall abnormalities remains a high-yield testing domain.

The central clinical question that this lesson addresses is: when a patient presents with dyspnea, pleuritic chest pain, or abnormal imaging of the thorax, how do you systematically evaluate the pleural space and chest wall to arrive at a diagnosis and institute appropriate management? Mastering this framework is essential not only for clinical rotations but also for the structured clinical vignettes that characterize USMLE Step 2 CK.

Core Principles & Definitions

Understanding pleural and chest wall disorders requires a firm grasp of normal pleural physiology. The pleural space is a potential space between the visceral pleura (adherent to the lung) and the parietal pleura (lining the thoracic cavity). Under normal conditions, approximately 0.1–0.2 mL/kg of serous fluid is present, maintained by a delicate balance of hydrostatic and oncotic pressures described by Starling forces, along with lymphatic drainage primarily through stomata on the parietal pleural surface. The intrapleural pressure is subatmospheric (approximately −5 cm H₂O at functional residual capacity), which keeps the lung expanded against the chest wall. Disruption of any component of this system—fluid balance, pleural membrane integrity, or chest wall mechanics—leads to the disorders discussed in this lesson.

Visual Explanation — Anatomy of the Pleural Space

In the diagram above, note how the lung (visceral pleura) is coupled to the chest wall (parietal pleura) by the thin pleural fluid layer. Starling forces govern fluid movement: systemic capillaries in the parietal pleura produce fluid at roughly 0.01 mL/kg/hr, while parietal pleural lymphatics reabsorb it. The visceral pleura, supplied by the pulmonary circulation (lower hydrostatic pressure), contributes less to fluid formation. Disruption of this balance—increased hydrostatic pressure (heart failure), decreased oncotic pressure (hypoalbuminemia), increased capillary permeability (infection, malignancy), or impaired lymphatic drainage—produces a pleural effusion. Alternatively, breach of the visceral pleura or chest wall allows air entry, causing pneumothorax.

Diagnostic Framework — Light's Criteria & Thoracentesis Analysis

The single most important diagnostic step in evaluating a new pleural effusion is thoracentesis with fluid analysis. Once fluid is obtained, Light's criteria remain the gold standard for differentiating transudative from exudative effusions. An effusion is classified as exudative if it meets any one of the following three criteria. If none are met, it is transudative.

Beyond Light's criteria, additional pleural fluid tests guide specific diagnoses. Fluid pH < 7.2 and glucose < 60 mg/dL suggest complicated parapneumonic effusion/empyema, rheumatoid pleurisy, or esophageal rupture. Pleural fluid adenosine deaminase (ADA) > 40 U/L in a lymphocyte-predominant exudate is highly suggestive of tuberculous pleurisy. Cytology identifies malignant cells in approximately 60% of malignant effusions on first tap, increasing to ~75% with repeated sampling. Triglycerides > 110 mg/dL confirm chylothorax (thoracic duct disruption), while cholesterol > 200 mg/dL with low triglycerides indicates pseudochylothorax (chronic trapped effusion).

Classification of Pleural Effusions & Pneumothorax

Pneumothorax Classification

Pneumothorax is classified by etiology and hemodynamic consequence. Primary spontaneous pneumothorax (PSP) occurs in young, tall, thin males without underlying lung disease, caused by rupture of apical subpleural blebs. Secondary spontaneous pneumothorax (SSP) occurs in patients with underlying pulmonary disease—most commonly COPD, but also cystic fibrosis, Pneumocystis pneumonia, or Marfan syndrome. SSP tends to be more clinically severe because these patients have limited pulmonary reserve. Tension pneumothorax is a medical emergency: a one-way valve mechanism allows air to accumulate progressively, causing mediastinal shift, decreased venous return, and obstructive shock. The clinical diagnosis—hypotension, distended neck veins, absent breath sounds, and tracheal deviation away from the affected side—demands immediate needle decompression at the second intercostal space, midclavicular line, followed by chest tube placement.

Worked Example — Pleural Effusion Evaluation

A 62-year-old woman with a history of breast cancer presents with progressive dyspnea over three weeks. Chest X-ray shows a moderate right-sided pleural effusion. Thoracentesis yields 800 mL of bloody fluid. Serum protein is 6.5 g/dL, serum LDH is 200 U/L (upper limit of normal = 250 U/L). Pleural fluid protein is 4.8 g/dL, pleural fluid LDH is 320 U/L. Determine whether this is a transudate or exudate and outline the next diagnostic steps.

Management Strategies — Comparing Approaches

Management of pleural disorders depends on the specific diagnosis, volume of effusion or pneumothorax, and patient symptoms. Here we compare the major therapeutic modalities used for pleural effusions and pneumothorax, highlighting their indications, advantages, and limitations.

Chest Wall Disorders & Advanced Pleural Pathology

Beyond effusions and pneumothorax, several chest wall and advanced pleural conditions appear on Step 2. Flail chest results from fracture of three or more contiguous ribs in two or more places, producing a free-floating chest wall segment that exhibits paradoxical motion—moving inward on inspiration and outward on expiration—severely impairing ventilation. Management focuses on pain control (epidural analgesia is preferred) and positive-pressure ventilation if needed, rather than surgical fixation in most cases. Kyphoscoliosis, when severe (Cobb angle > 70°), produces restrictive lung disease by reducing chest wall compliance and total lung capacity. Over time, chronic hypoventilation leads to hypercapnic respiratory failure and cor pulmonale. Mesothelioma, the most important primary pleural malignancy, is strongly associated with occupational asbestos exposure with a latency period of 20–40 years. Imaging characteristically shows unilateral pleural thickening with effusion, and diagnosis requires pleural biopsy. Prognosis is poor, with median survival of 12–18 months.

Looking ahead to clinical practice and further study, these disorders connect to advanced topics including indications for decortication in chronic empyema with trapped lung, the role of pleuromanometry in distinguishing trapped lung from lung entrapment, and the emerging role of immunotherapy in mesothelioma management. On Step 2, focus on recognizing the clinical presentations, understanding the diagnostic algorithm (especially Light's criteria and pneumothorax management), and knowing the urgent interventions—these are the most commonly tested elements.

Practice Problems

Lesson Summary